CALIWAY ANNOUNCES POSITIVE PHASE 2 RESULTS OF CBL-514 IN DERCUM'S DISEASE, ACHIEVING PRIMARY ENDPOINT WITH STATISTICALLY SIGNIFICANT AND SUSTAINED PAIN REDUCTION

Reuters · 3d ago

Please log in to view news